大学生强迫症现况调查及SAPAP3基因多态性关联研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
近年来,国内外大量心理健康状况的研究结果表明,大学生中存在着各种不同程度的心理疾病。强迫症是大学生所患心理疾病中痛苦程度较高的顽症,且呈现出逐渐升高的趋势。其症状典型、特异性高、病程较长、治疗困难,严重影响了大学生的学习和生活。目前,针对强迫症的研究主要集中在临床群体,而对于非临床大学生的研究为数不多。
     本研究遵循“现况调查-实验检测-理论分析”的思路,以某综合性大学的2046名本科生为研究对象。在大量文献阅读的基础上,通过流行病学的现况调查,分析大学生强迫症的流行病学特征和临床特点,探索影响大学生强迫症的相关因素。利用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)方法检测Sapap3基因上的rs11264155 tag SNP位点,初步探索Sapap3基因多态性与大学生强迫症的关系。调查结果显示,强迫症在大学生群体中检出率较高,有明显的性别和年级差异,并受家庭环境、儿童时期父母的教养方式和社会支持程度等方面的影响。实验结果显示,Sapap3基因多态性与大学生强迫症及其临床症状之间无关联。
     本研究为高校实施大学生心理健康教育提供了科学的理论依据,并为强迫症的易感基因研究奠定了基础。建议学校、家庭和社会建立三级支持系统,预防大学生强迫症的发生。
Obsessive Compulsive Disorder is a chronic mental illness of higher degree among undergraduates, and the incidence rate of OCD in undergraduates has continued rising trend, which has seriously affected the living and learning of undergraduates. At present, most research of OCD is mainly focused on the clinical community. However, specific studies on the non-clinical community of undergraduates are much less carried out. Therefore, this study has important theoretical and practical value. Objective
     By means of epidemiological investigation and molecular genetics technology, analyze the prevalence characteristics and clinical features of OCD undergraduates, discusse the relevant factors and investigate the genetic association between Sapap3 gene polymorphism and OCD in undergraduates.
     Methods
     1. The epidemiology of OCD in undergraduates.
     This research takes 2046 undergraduates in a comprehensive University in Jilin for study. By the use of World Health Organization Composite International Diagnostic (WHO-CIDI 3.0), interviewed undergraduates in face-to-face standardized. Under the computer diagnostic procedures provided by WHO, diagnosed OCD in undergraduates. By the statistical method ofχ2 test, analysis of variance, t-test analysis to analyse the characteristics of gender, age, source, clinical sympotoms, family environment, childhood and social nets. Through correlation analysis and regression statistical methods, explore risk factors of OCD undergraduates.
     2. Sapap3 gene polymorphism test
     In this research, 190 cases of OCD and 190 normal controls were selected in undergraduates with age、sex and subject in match. With the informed consent of subjects, collecting saliva of undergraduates, using Promega (Promega, United States) liquid extract DNA Purification Kit, extraction of genomic DNA. The polymerase chain reaction (PCR) and restrictive fragment length polymorphism (RFLP) were applied to detect the gene types of Sapap3 the rs11264155 in OCD undergraduates. Application of goodness-of-fitχ2 test, the calculation of the SNP sites genotype frequency distribution is consistent with the Hardy-Weinberg equilibrium; applicationχ2 test of the SNP sites and clinical types of OCD.
     Results
     1. The lifetime prevalence rate of OCD undergraduates is 13.67%, 12-month prevalence rate is 6.19%. 30-day prevalence rate is 2.12%; Male prevalence is significant higher than female (χ2=5.474, P=0.019); There were found differences in different grades(χ2=16.479,P=0.001), the performance of the freshman and sophomore higher than junior and senior.
     2. The OCD in undergraduates mainly in the type of mixed-oriented (45.24%), followed by the Obsessive (35.71%) and Compulsive (19.05%). The highest frequency of OCD symptom is aggressive obsessions (63.49%), following by symmetry obsessions (42.46%) and sexual obsessions (38.89%). There were found sex differences exist in symmetry obsessions(χ2=8.442,P=0.004)、sexual obsession(sχ2=6.488,P=0.012)and ordering compulsions(χ2=6.719,P=0.010).
     3. Through single factor analysis, there were found several influence factors: gender、grades、parents moods、father occupational status、mother strict controls、parents is low-density、social exchanges、family conflicts and so on . Through multi-factor analysis, there were found risk factors: gender、grades、mood of mother、father occupational status、relationship with parents、look after by partents and family conflicts.
     4. Sapap3 gene rs11264155 sites, genotype frequencies of case group and control group was not significant(P=0.300)and allele frequencies of case group and control group was also not significan(tχ2=2.295,P=0.130). The genotype and allele distribution between two groups in OCD type and sympotoms were not significant.
     Conclusions
     OCD performance higher prevalence in undergraduates, and exist significant differences in sex and grades; The OCD undergraduates mainly in the type of mixed-oriented, and mainly in the sympotoms of aggressive、symmetry and sexual obsessions. The OCD undergraduates imfluenced by family backgrounds、Childhoods and Social net; Sapap3 gene rs11264155 sites were not found significant with OCD of undergraduates.
引文
1. Esquirol JED: De la monomanie, in Des maladies mentales. Brussels, Belgium, JB Baillirie, 1838.
    2. Freud S. Obsessive acts and religious practices. In: Strachey Y. The Standard Edition of the Complete Psychological Works of Sigmund Freud.London Hogarth Press, 1907, 9: 167–175.
    3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC. American Psychiatric Press, 1994.
    4. Akhtar S, Wig NN, Varma VK, Pershad D, Verma SK. A phenomenological analysis of symptoms in obsessive-compulsive neurosis. Br J Psychiatry, 1975, 8:127–342.
    5. Wilne A,Reieh T,Robins I,Fishman R &vanDoren T. Obsessive Compulsive neuroses. Comprehensive psyehiatry, 1976, 17:527–539.
    6. Henderson J.G. &Pollard C.A. Three types of obsessive compulsive disorder in aconununity sample. Joumal of Clinical Psychology, 1988, 44:747–752.
    7. Ravindran A. V, Griffiths J, Merealiz, Anisman H. Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. J Affect Disorder, 1999, 52:1–10.
    8. Micallef J, Blin O. Neurobiology and clinical pharmacology of obsessive compulsive disorder. Clin. Neuropharmacol, 2001, 24:191–207.
    9. 郭慧荣,肖泽萍,张海音.强迫症流行病学研究进展.上海精神医学,2003, 15(3):179–182.
    10. Lesage AD, Cyr M, Toupin J, Cormier H, Valiquette C. Training of interviewers in the utilization of standardized questionnaires in psychiatry: studies realized with the Present State Examination (PSE). Acta Psychiatr Belg, 1991, 3:129–44.
    11. Goodman WK, Price LH, Rasmussen SA. The Yale–Brown Obsessive CompulsiveScale. II. Validity. Arch.Gen. Psychiatry, 1989, 46: 1012–1016.
    12. Robins L.N, Helzer J.E, Weissman M.M, Orvaschel H, Gruenberg E, Burke Jr J.D, Regier D.A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry, 1984, 41:949–958.
    13. Karno M, Golding JM. Obsessive-compulsive disorder. In Robins LN, Regier DA (eds): Psychiatric disorders in American. The epidemiologic cathment area study. New York. The Free Press, 1991: 204–219.
    14. Meltzer H, Gill B, Petticrew M, Hinds K. OPCS surveys of psychiatric morbidity in Great Britain. Report No 1. The prevalence of psychiatric morbidity among adults living private Households Londond: office of population censuses and surveys, 1995.
    15. Jenkins R, Bebbinbgton PE, Brugha T. The national psychiatric morbidity surveys of Great Britain: Strategy and methods. Psychological Medicine, 1997, 27: 765–774.
    16. Samuels J, Nestadt G. Epidemiology and genetics of obsessive-compulsive disorder. Int Rev Psychiatry, 1997, 9:61–71.
    17. Leckman JF, Zhang HP, Alsobrook JP. Symptom dimensions in obsessive compulsive disorder: toward quantitative phenotypes. Am J Med Genet, 2001, 105: 28–30.
    18. 张伯全,崔玉华,沈渔邨.强迫症与分裂型障碍共病的临床研究.山东精神医学,2006, 29(1):1–5.
    19. Nelson E, Rice J. Stability of diagnosis of obsessive compulsive disorder in the Epidemiologic Catchment Area study. Am. J. Psychiatry, 1997, 154: 826–831.
    20. du Toit PL, van Kradenburg J, Niehaus D, Stein DJ. Comparison of obsessive–compulsive disorder patients with and without comorbid putative obsessive–compulsive spectrum disorders using a structured clinical interview. Compr. Psychiatry, 2001, 42: 291–300.
    21. Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM.Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample. Depress Anxiety, 1996, 4:111–119.
    22. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry, 1988, 45:1094–1099.
    23. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickramaratne PJ, Wittchen H, Yeh EK (Cross National Collaborative Group). The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry, 1994, 55(suppl):5-10.
    24. Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiologyof obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry, 2006, 30: 327-37.
    25. 沈渔邨,等.国内 12 地区精神疾病流行病学调查的方法学及资料分析.中华神经精神科杂志,1986,19(2):65–69.
    26. Cavallini MC, Albertazzi M, Bianchi L, Bellodi L. Anticipation of age at onset of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder. Psychiatry Res, 2002, 111:1–9.
    27. Lensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL, Akiskal HS. Obsessive compulsive disorder. Familial developmental history, symptomatology, comorbidity and course with special reference to gender related differences. Br J Psychiatry, 1996, 169:101-107.
    28. Ackerman D.L, Greenland S, Bystritsky A. Clinical characteristics of response to fluoxetine treatment of obsessive compulsive disorder. J. Clin. Psychopharmacol, 1998, 18:185– 192.
    29. Andres S, Boget T, Lazaro L, Penades R, Mores A, Salamero M. Neuropsychologicalperformance in children and adolescents with obsessive-compulsive disorder and influence of clinical variables. Biological Psychiatry, 2007, 61: 946–51.
    30. Maina G, Albert U, Bogetto F. Recent life events and obsessive-compulsive disorder (OCD): the role of Pregnancy/ delivery. Psyehiatry-Res, 1999, 89(l):49–58.
    31. Apter A, Fallon TJ, King RA. Obsessive compulsive characteristics: from symptoms to syndrome.J Am Acad Child Adolesc Psychiatry, 1996, 35:907 – 912.
    32. Reiger D.A, Boyd H.H&Burke J.D. One-month prevalence of mental disorders in the United States. Archives of General Psychiatry, 1988, 45:977–978.
    33. Zohar AH, Ratzoni G, Pauls DL, Apter A, Bleich A, Kron S, Rappaport M, Weizman A, Cohen DJ. An epidemiological study of obsessive compulsive disorder and related disorders in Israeli adolescents. J Am Acad Child Adolesc Psychiatry, 1992, 31:1057–1061.
    34. Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T. Epidemiology of obsessive-compulsive disorder: A world view. Journal of Clinical Psychiatry, 1997,58 (Suppl.12): 7–10.
    35. Reinherz HZ, Giaconia RM, Lefkowitz ES, Pakiz B, Frost AK. Prevalence of psychiatric disorders in a community population of older adolescents. J Am Acad Child Adolesc Psychiatry, 1993, 35:369–377.
    36. Rapoport JL, Elkins R, Mikkelson E. A clinical controlled trial of cholorimipramine in adolescents with obsessive-compulsive disorder. Psychopharmacology Bulletin, 1980, 16:62–63.
    37. Bebbington PE. Epidemiology of obsessive-compulsive disorder. British Journal of Psychiatry, 1998, 35:2–6.
    38. Bogetto F, Venturello S, Albert U, Maina G, Ravizza L. Gender-related clinical differences in obsessive compulsive disorder. Eur. Psychiatry, 1999, 14:434–441.
    39. First MB, Spitzer RL, Gobbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders Patient Edition (SCID-I/P, Version 2.0, 8/98Revision). New York State Psychiatric Institute, Biometrics Research Department, New York, 1998.
    40. Finkelhor D, Hotaling G, Lewis I.A, Smith C. Sexual abuse in a national survey of adult men and women: prevalence, characteristics, and risk factors. Child Abuse Negl, 1990, 14:19–28.
    41. Hemmings, S.M.J, Kinnear, C.J, Niehaus D.J.H, Moolman-Smook J.C, Knowles J.A, Lochner C, and Corfield V.A, Stein D.J. Dopaminergicand serotonergic system genes in obsessive compulsive disorder: a case-control association study in the Afrikaner population. Eur. Neuropsychopharmacol, 2003, 13: 93–98.
    42. Lochner C, Stein D.J. Gender in obsessive compulsive disorder and obsessive compulsive spectrum disorders a literature review. Arch. Women’s Mental Health, 2001, 4:19– 26.
    43. Castle D.J, Deale A, Marks I.M. Gender differences in obsessive compulsive disorder. Aust. N. Z. J. Psychiatry, 1995, 29:114–117.
    44. Neziroglu F, Anemone R, Yaryura-Tobias J.A. Onset of obsessive–compulsive disorder in pregnancy. Am. J. Psychiatry, 1992, 149:947–950.
    45. Stein D.J. Neurobiology of the obsessive–compulsive spectrum disorders [J]. Biol. Psychiatry, 2000, 47: 296– 304.
    46. Phillips KA, McElroy SL, Hudson JI, Pope HC. BodyDysmorphic Disorder: An Obsessive Compulsive Spectrum Disorder, a form of Affective Spectrum disorder or both. J Clin Psychiatr, 1995, 56: 41–51.
    47. Pfizer N, Andrade C. Isolated Musical Obsessions. Ind J. Psychiatr, 1999, 41:77–78.
    48. Rasmussen S A, Eisen J L. Epidemiology of obsessive compulsive disorder. Journal of Clinical Psychiatry, 1990, 51:10–14.
    49. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry, 1995, 152:76–84.
    50. Samuels JF, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Pinto A, Knowles JA, Piacentini J, Cannistraro PA, Cullen B, Bienvenu OJ, Rasmussen SA, Pauls DA, Willour VL, Shugart YY, Liang KY, Hoehn-Saric R, Nestadt G. The OCD Collaborative Genetic Study: methods and sample description. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 2006, 141B: 201–207.
    51. 杨彦春,刘协和.强迫症的家系遗传研究.中华医学遗传学杂志,1998,15(5): 303–306.
    52. Jonnal AH, Gardner CO, Prescott CA, Kendler KS. Obsessive and compulsive symptoms in a general population sample of female twins. Am J Med Genet, 2000, 96: 91–796.
    53. Black DW, Noyes R Jr, Goldstein RB, Blum N. A family study of obsessive compulsive disorder. Arch Gen Psychiatry, 1992, 49:362–368.
    54. Fyer AJ, Mannuzza S, Chapman TF, Liebowitz MR, Klein DF. A direct interview family study of social phobia. Arch Gen Psychiatry, 1993, 50:286–293.
    55. Nestadt G, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, LaBuda M, Walkup J, Grados M, Hoehn-Saric R. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry, 2000, 57:358–363.
    56. McKeon P, Murray R. Familial aspects of obsessive-compulsive neurosis. Br J Psychiatry, 1987, 151:528–534.
    57. Hanna GL, Fingerlin TE, Himle JA, Boehnke M. Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Hum Hered, 2005, 60:1–9.
    58. Hanna GL, Himle JA, Curtis GC, Gillespie BW. A family study of obsessive compulsive disorder with pediatric probands. Am J Med Genet B Neuropsychiatry Genet, 2005, 134:13–19.
    59. Inouye E. Similar and dissimilar manifestations of obsessive-compulsive neurosis in monozygotic twins. Am J Psychiatry, 1965, 21:1171–1175.
    60. Carey G, Gottesman II. Twin and family studies of anxiety, phobic and obsessive disorders. Anxiety: new research and changing concepts. New York: Raven Press, 1981, 117–136.
    61. Eley TC, Bolton D, O'Connor TG, Perrin S, Smith P, Plomin R. A twin study of anxiety-related behaviours in pre-school children. J Child Psychol Psychiatry, 2003, 44(7): 945–960.
    62. Andrews G, Stewart G, Allen R, Henderson A S. The genetics of six neurotic disorders: A twin study. Journal of Affective Disorder, 1990, 19: 23–29.
    63. Grados MA, Riddle MA, Samuels JF, Liang KY, Hoehn-Saric R, Bienvenu OJ, Walkup JT, Song D, Nestadt G. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: The Hopkins OCD family study. Biol Psychiatry, 2001, 50:559–565.
    64. Williams R.B, Marchuk D.A, Gadde K.M, Barefoot J.C, Grichnik K, Helms M.J, Kuhn C.M, Lewis J.G, Schanberg S.M, Stafford-Smith M, Suarez E.C, Clary G.L, Svenson I.K, Siegler I.C. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology, 2003, 28 (3): 533–541.
    65. Denys D, Zohar J, Westenberg H.G. The Role of Dopamine in Obsessive Compulsive Disorder: Preclinical and Clinical Evidence. J. Clin. Psychiatry, 2004, 65 (Suppl. 14):11–17.
    66. Yaryura-Tobias JA, Neziroglu FA. Obsessive-Compulsive Disorder Spectrum.Washington, DC: American Psychiatric Press, 1997.
    67. Fineberg NA, Roberts A, Montgomery SA. Brain 5-HT function in obsessive compulsive disorder. Br J Psychiatry, 1997, 171:280–282.
    68. Catalano M, Sciuto G, Di Bella D. Lack of association between obsessive-compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am J Med Genet, 1994, 54:253–255.
    69. Trivedi MH: J Clin Psychiatry, 1996; 57 (supp 18): 26–36.
    70. Luxemberg JS, Swedo SE, Flament MF, Friedland RP, Rapoport J, Rapoport SI. Neuroanatomical abnormalities in obsessive compulsivedisorder detected with quantitative X-ray computed tomography. Am J Psychiatry, 1988, 145(9):1089-93.
    71. Robinson D, Wu H, Munne RA, Ashtari M, Alvir JM, Lerner G, Koreen A ,Cole K, Bogerts B. Reduced caudate nucleus volume in obseesive compulsive disorder. Arch Gen. Psychiatry, 1995, 52:393–398.
    72. Risch N. Searching for genes in complex diseases: leansons from sysytemic lupus. Erythematosus. J. clin. Invert, 2000, 105: 1503–1506.
    73. Swedo SE, Leonard HL, Mittleman BB. Identification of children with Pediatric autoimmune neuropsychiatric disorders associated with rheumatic fever. Am J Psychiatry, 1997, 154: 110–112.
    74. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatries disorders associated with streptococcal infections (PANDAS): A clinical of the first fifty cases. Am J Psychiatry, 1998, 155:264–271.
    75. Marazziti D, PrestaS, Pfanner C. Immunological alternations in adult obsessive compulsive disorder. Biol Psychiatry, 1999, 46:810–814.
    76. Monteleone P, Catapano F, Fabrazzo M. Decreased blood level of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology,1998, 37:182–185.
    77. Risch NJ, Zhang H. Mapping quantitative trait loci with extreme discordant sib pairs: sampling considerations. Am J Hum Genet, 1996, 58(4):836–43.
    78. 方唯意,姚开泰.高通量 SNP 基因分型技术研究进展.医学分子生物学杂志,2003, 25(6):333–336.
    79. Gabriel SB, Schaffner SF, Nguyen H. The structure of haplotype blocks in the human genome. Science, 2002, 296(5576): 2225-2229.
    80. Gray IC, Campbell DA, Spurr NK; Single nucleotide polymorphisms as tools in human genetics. Human Molecular Genetics, 2000, 9(16):2403-8.
    81. Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F. 5-HT1Dbeta receptor gene implicated in the pathogenesis of obsessive compulsive disorder: Further evidence from a family-based association study. Mol Psychiatry, 2002, 7:805–809.
    82. Cruz C, Camarena B, King N. Increased prevalence of the seven repeat variant of the dopamine D4 receptor gene in patients with obsessive compulsive disorder with tics. Neurosci Lett, 1997, 231:1–4.
    83. Millet B, Chabane N, Delorme R , Leboyer M, Leroy S, Poirier MF, Bourdel MC, Mouren-Simeoni MC, Rouillon F, Loo, H, Krebs MO. Association between the dopamine receptor D4(DRD4)gene and obsessive compulsive disorder. Am.J Med. Genet B. N europsychiatr Genet, 2003, 116:55–59.
    84. Karayiorgou M, Sobin C, Blundell JL. Family-based association studies support a sexually dimorphic effect of COMT and MAO-A on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry, 1999, 45:1178–1189.
    85. Kennedy JL. Investigation of the myelin?o ligodendrocyte gtycoprotein (MOG) and HLA region CA repeat Lociin obsessive compulsive disorder. Presented at the 5th International Obsessive CompulsiveD is order Conference. Sardinia Italy, 2001,25–26.
    86. Enoch M, Greenberg BD, Murphy DL, Goldman D. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive compulsive disorder. Biol. Psychiatry, 2001, 49 (4): 385–388.
    87. Mundo E, Richter MA, Sam F, Macciardi F, Kennedy JL. Is the 5-HT (1b) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder? Am J Psychiatry, 2000, 157:1160–1161.
    88. Kent L, Green E, Hawi Z, Kirley A, Dudbridge F, Lowe N. Association of the paternally transmitted copy of common valine allele of the val66met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry, 2005, 10:939–943.
    89. Torgersen S. Genetic factors in anxiety disorders. Arch Gen Psychiatry, 1983, 40:1085–1089.
    90. Szekely A, Ronai Z, Nemoda Z, Kolman G, Gervai J, Sasvari-Szekeli M. Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am. J. Med. Genet B Neuropsychiatr. Genet, 2004, 126: 106–110.
    91. Nicolini H, Cruz C, Camarena B. DRD2, DRD3 and 5-HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry, 1996, 1(6): 461–465.
    92. Bengel D, Greenberg B, Cora-Locatell G, Altemus M, Heils A, Li Q, Murphy D. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive compulsive disorder. Mol. Psychiatry, 1999, 4 (5): 463–466.
    93. McDougle C.J, Epperson C.N, Price L.H, Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessivecompulsive disorder. Mol. Psychiatry, 1998, 3 (3): 270–273.
    94. Walitza S, Wewetzer C, Warnke A, Gerlach M, Geller F, Gerber G, Gorg T, Herpertz-Dahlmann B, Schulz E, Remschmidt H, Hebebrand J, Hinney A. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive compulsive disorders. Mol. Psychiatry, 2002, 7 (10):1054–1057.
    95. Richter MA. The GABA-A-r gene in OCD and social phobia. P resented at the 5th International Obsessive Compulsive Disorder Conference, Sardinia Italy, 2001, 292: 19–21.
    96. Delorme R, Krebs MO, Chabane N, Roy I, Millet B, Mouren-Simeoni MC, Maier W, Bourgeron T, Leboyer M. Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport, 2004, 15:699–702.
    97. Kim SJ, Veenstra-Vander Weele J, Hanna GL. Mutation screening of human 5-HT2B receptor gene in early-onset obsessive compulsive disorder. Mol Cell Probes, 2000, 14:47–52.
    98. Chabane N, Millet B, Delorme R, Lichtermann D, Mathieu F, Laplanche JL. Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive compulsive disorder by case control and family association study in humans. Neurosci Lett, 2004, 363:154–6.
    99. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH, Hanna GL. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessivecompulsive disorder. Arch Gen Psychiatry, 2006, 63:778–785.
    100. 肖泽萍,张明岛,王振,等.强迫症、抑郁症及焦虑症患者血小板 5-羟色胺浓度的对照研究[J].中华精神科杂志,2002,36(4):211–214.
    101. 王振,肖泽萍,江三多,等.儿茶酚胺邻甲基转移酶基因多态性与强迫症临床特征的关联分析[C].中华医学会精神病学会第五次全国学术年会论文集,上海, 2003, 15(3):137-139.
    102. Jeffrey M. Welch, Jing Lu, Ramona M. Rodriguiz, Nicholas C. Trotta, Joao Peca, Jin-Dong Ding, Catia Feliciano, Meng Chen, J. Paige Adams, Jianhong Luo, Serena M. Dudek, Richard J. Weignerg, Nicole Calakos, William C. Wetsel&Guoping Feng. Cortico-striatal synaptic defects and OCD like behaviours in Sapap3-mutant mice. Nature, 2007, 448:894–900.
    103. 张守杰,许又新.强迫症症状学的初步研究.中国心理卫生杂志, 1991, 5(2):79–81.
    104. 吴承红,蔡澄.大学生强迫症症状学的研究.扬州大学学报,2002,6(3):32–34.
    105. 赵勇.大学生强迫症状况调查及其个性分析.中国健康心理学杂志,2005,13 (6):19–20.
    106. Douglass HM, Moffitt TE, Dar R. Obsessive compulsive disorder in a birth cohort of 18-year-olds: prevalence and prevalence and predictors. Journal of the American Academy of China and Adolescent. Psychiatry, 1995, 34:1424–1431.
    107. Canals J, Domenech E, Carbajo G. Prevalence of DSM-III-R and ICD-10 psychiatric disorders in a Spanish population of 18-year-olds. Acta Psychiatrica Scandinabica, 1997, 98:287–294.
    108. 韩彩萍.对西北大学大学生 SCL–90 评定结果的分析.西北大学学报(自然科学版),1994, 24(6):557–560.
    109. 丁秀玲,陈蓉蓉.财经类大学生心理健康水平的调查与分析.南京经济学院学报,1997, (6):54–59.
    110. 刘迎春.大学新生 SCL–90 测试结果分析.浙江师大学报, 2001, 26 (3):12–15.
    111. 殷炳江,刘春蕾.2290 名大学生 EPQ 及 SCL─90 测查分析.中国心理卫生杂志, 1996,S1:072.
    112. 高成阁,王友平,亢万虎,等.陕西省大中学生心理健康水平调查.中国临床心理学杂志,1997,5(1):37–38.
    113. 周小林,程虹娟,陈华.对 2177 名大学生心理健康状况的分析.四川精神卫生, 2000, 13(2):122–123.
    114. 韦克平.大学生心理健康状况调查与分析.广西民族学院学报,2000, 6(2):136–140.
    115. Sununerfeldt LJ, Richter MA,Antory MM, Swinson RP. Symptom structure in obsessive compulsive disorder: a confirmatory factor analytic study. Behavior Research and Therapy, 1999, 37:297–311.
    116. 黄政昌.《强迫症门诊患者的临床特征与联合治疗模式效果之分析研究》2003, 71–91.
    117. Anotony MM, Downie F, Swinson RP. Diagnostic Issues and Epidemiology in Obsessive Compulsive Disorder. Obsessive. New York: Guilford.Theory, Research and Treatment, 1998, 3–27.
    118. Checkers, Washers. Valid Subtypes of Obsessive Compulsive Disorder. Psychopathology, 1992, 25: 283–288.
    119. 毛富强.医科大学生心理健康状况比较分析.天津医科大学学报,1999,5(1): 27–31.
    120. 诺敏,武慧多.高师新生心理健康状况调查研究.内蒙古师范大学学报教育科学版, 2005,18(7):63–65.
    121. 赵光国,曾昭祥,郭军.强迫症患者家庭环境及父母教育方式的对照研究.健康心理学杂志, 2003,11(3):186–187.
    122. 王艳玲,翟宏.家庭教育方式与强迫性神经症.赣南师范学院, 1998, (l):80–82.
    123. 管新丽,马书礼,李曙亮.青少年强迫症患者父母教养方式的特征.中国临床康复, 2004, 8(33):7357.
    124. 郭兰婷,张志群.青少年自评量表与儿童行为量表相关性研究.中国心理卫生杂志, 2002, 16(9): 636–639.